Log In
BCIQ
Print this Print this
 

KD034

  Manage Alerts
Collapse Summary General Information
Company Kadmon Holdings Inc.
DescriptionEnhanced formulation of trientine hydrochloride, a chelating compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationWilson's disease
Indication DetailsTreat Wilson's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today